DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Sadoff J, Le Gars M, Shukarev G. et al
Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial: MedRxiv.
WHO 2020;
DOI: 10.1101/2020.09.23.20199604.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.